Particularly, the expression of CD31 and VEGF was significantly downregulated in the Gef/H-dot+Gen/H-dot group compared with other groups by changing the tumor microenvironment due to the high efficacy of anti-angiogenesis accompanied with remarkable tumor regression suggesting excellent synergistic therapeutic efficacy (Figure 6B). The gene discussed is VEGFA; the disease is neoplasm.